SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: Vector1 who wrote (665)7/3/2002 9:00:36 AM
From: RCMac   of 666
 
Adding this post to make sure that this thread (dormant since CRXA acquired Coulter) doesn't go away.

Some of the posts here may be useful as FDA looks again at Bexxar, on CRXA's appeal -- perhaps especially the December 1999 discussion of Bexxar among Gordon James (reporting from the ASH meeting in New Orleans) and several biomavens, including Biomaven, Vector1, Rick Harmon, biowa, et al.

That series of posts starts here: Message 12182587
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News